Astellas Institute for Regenerative Medicine v Healios K.K (CFI, UPC_CFI_80/2023, 11 October 2023)
| Date | 11 October 2023 |
|---|---|
| Court | CFI |
| Division | Munich (DE) Central Division - Section |
| Type of action | Revocation Action |
| Case number(s) | UPC_CFI_80/2023 |
| Registry reference | ORD_579545/2023 · UPC_CFI_80/2023 |
| Parties | ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE v. HELIOS K.K, RIKEN |
Official decision (PDF) · UPC registry entry
Case timeline
- 17 November 2023 : Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, 17 November 2023) ORD_584830/2023 · UPC_CFI_80/2023
- 20 November 2023 : Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 20 November 2023) ORD_579547/2023 · UPC_CFI_80/2023
- 18 March 2024 : Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 18 March 2024) ACT_465342/2023 · ORD_598256/2023 · UPC_CFI_80/2023
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By procedural order of 11 October 2023 (UPC_CFI_80/2023, ORD_579545/2023, ACT_465342/2023), the judge-rapporteur of Panel 1 of the Munich Central Division (A. Kupecz), in Astellas Institute for Regenerative Medicine’s revocation action against EP 3 056 564 held by Healios K.K and Osaka University, ruled that the Defence to revocation is deemed served on the claimant on 29 September 2023. The notification generated by the case management system (CMS) is service, without any specific communication from the court.
Question
Was the Defence to revocation, filed on 13 September 2023 in an unsuitable CMS workflow and refiled on 29 September 2023 in the « Defence » workflow, served on the claimant in the absence of a separate communication from the court, and if so on what date?
Decision
Parties must in principle use the CMS and its dedicated workflows and bear sole responsibility for filing correctly and on time (Rule 4.1 RoP), given that the system is new, the court helps to resolve difficulties, as it did by inviting the defendants to refile, but submissions and correspondence outside the CMS should be kept to a minimum. The CMS notification is the means of electronic communication under Rule 278.1 RoP, or the relevant electronic message under Rule 271.6 RoP, which applies to pleadings through Rule 278.4 RoP, no further specific communication from the court is required, contrary to the defendants’ submission. As the claimant had taken 29 September 2023 and no objection to that date was raised, the court accepted it. The time limit for responding to the request for a stay under Art. 33(10) UPCA will be set by a separate order (App_577540/2023), panel review may be requested within 15 days (Rule 333 RoP).
Key points for practice
- Practical point: service of a pleading results from the automatic CMS notification where the filing uses the correct workflow, filing in the wrong workflow may delay the start of time limits.
Provisions applied
- Agreement on a Unified Patent Court
- Art. 33(10)
- Rules of Procedure
- Rules 4.1, 6.1(b), 9, 32, 51, 271.6, 278.1, 278.4, 278.5 and 333
Related decisions
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Decisions in the same proceedings
Going further
Lexicon: Revocation action.
Publications by Matthieu Dhenne: G 1/25, Take Three: Anything You Leave in the Description May Be Used Against You (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- defendantRIKEN7 decisions in the corpusFollow this party
- claimantASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE10 decisions in the corpusFollow this party
- defendantHELIOS K.K4 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
- 11 October 2023 Astellas Institute for Regenerative Medicine v Healios K.K (CFI, UPC_CFI_80/2023, 11 October 2023) Revocation Action · UPC_CFI_80/2023
- 17 November 2023 Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, 17 November 2023) Revocation Action · UPC_CFI_80/2023
L'annexe confidentielle n'est accessible qu'aux représentants des défenderesses et à trois personnes physiques désignées, dont un conseil externe. Elle est soustraite à l'accès des tiers et l'appel est autorisé.
- 20 November 2023 Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 20 November 2023) Revocation Action · UPC_CFI_80/2023
Le sursis à statuer sur l'action en nullité est refusé : une décision de la division d'opposition proche mais susceptible de recours n'emporte pas, à ce stade, une décision rapide justifiant la suspension, l'appel est autorisé.
- 18 March 2024 Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 18 March 2024) Revocation Action · UPC_CFI_80/2023
Le document D21 est admis sous réserve d'une réponse de la défenderesse avant le 11 avril 2024, la valeur du litige est fixée à 4 000 000 euros et l'audience confirmée au 26 juin 2024.
What the record states
- Nature of the act
- Revocation Action
- Outcome (Dhenne Avocats summary)
- Le mémoire en défense à l'action en nullité est réputé signifié à la demanderesse le 29 septembre 2023, le délai de réponse à la demande de sursis sera fixé par une ordonnance distincte.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 3 056 564mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 18 March 2024) cited in this record
- Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 20 November 2023) cited in this record
- Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, 17 November 2023) cited in this record
- Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, ORD_465342/2023, 16 June 2023) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 056 564 | Mentioned in the analysis (role not qualified) Also mentioned in 6 other decision(s): Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 23 Ju · Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 18 Ma · Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 20 No · Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, 17 N · Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, ORD_ · Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, ORD_ | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.